Medications starting with

Poland
  • RIVAROXABAN STADA

    The medicine is used in adults to treat blood clots in the veins of the legs (deep vein thrombosis) and blood vessels of the lungs (pulmonary embolism), as well as to prevent the recurrence of such clots.

    Dosage form: capsules, hard

    Active substance Dosage
    rivaroxaban 15 mg or 20 mg

    ATC code: B01AF01

    Manufacturer: Stada AG

  • In adults, it is used to prevent strokes and other blood clots (in atrial fibrillation) and for the treatment and prevention of deep vein thrombosis and pulmonary embolism. In children and adolescents (weighing more than 30 kg), it is used for the treatment and prevention of blood clots in the veins or lungs.

    Dosage form: capsules, hard

    Active substance Dosage
    rivaroxaban 20 mg

    ATC code: B01AF01

    Manufacturer: Stada AG

  • This medicine is used in adults to prevent strokes and other blood clots (e.g., in atrial fibrillation) and to treat deep vein thrombosis and pulmonary embolism. In children and adolescents (weighing more than 30 kg), it is used to treat and prevent blood clots in the veins or lungs.

    Dosage form: tablets, film-coated

    Active substance Dosage
    rivaroxaban 15 mg

    ATC code: B01AF01

    Manufacturer: Chanelle Medical Unlimited Company

  • This medicine is used in adults to prevent strokes and other blood clots (e.g., in atrial fibrillation) and to treat and prevent blood clots in the leg veins and pulmonary vessels. In children and adolescents (weighing more than 30 kg), it is used to treat blood clots in the veins or lungs.

    Dosage form: tablets, film-coated

    Active substance Dosage
    rivaroxaban 20 mg

    ATC code: B01AF01

    Manufacturer: Chanelle Medical Unlimited Company

  • In adults, it is used to prevent strokes and other blood clots (e.g., in atrial fibrillation) and to treat and prevent blood clots in the leg and lung veins. In children and adolescents (weighing over 30 kg), it is used to treat blood clots after initial injectable treatment.

    Dosage form: tablets, film-coated

    Active substance Dosage
    rivaroxaban 20 mg

    ATC code: B01AF01

    Manufacturer: ELPEN Pharmaceutical Co. Inc.

  • In adults, the medicine is used to prevent strokes and other blood clots (e.g., in atrial fibrillation) and to treat and prevent blood clots in the leg veins and pulmonary vessels. In children and adolescents (over 30 kg), it is used to treat and prevent clots in the veins or lungs after initial treatment with injectable medicines.

    Dosage form: tablets, film-coated

    Active substance Dosage
    rivaroxaban 15 mg

    ATC code: B01AF01

    Manufacturer: ELPEN Pharmaceutical Co. Inc.

  • The medicine is used in adults to prevent the formation of blood clots in the veins after hip or knee replacement surgery, and to treat deep vein thrombosis and pulmonary embolism, as well as to prevent their recurrence.

    Dosage form: tablets, film-coated

    Active substance Dosage
    rivaroxaban 10 mg

    ATC code: B01AF01

    Manufacturer: ELPEN Pharmaceutical Co. Inc.

  • This medicine is used in adults to reduce the risk of a subsequent heart attack or death from cardiovascular disease (following a diagnosis of acute coronary syndrome). It is also used to reduce the risk of blood clots in people with coronary artery disease or peripheral artery disease.

    Dosage form: tablets, film-coated

    Active substance Dosage
    rivaroxaban 2.5 mg

    ATC code: B01AF01

    Manufacturer: ELPEN Pharmaceutical Co. Inc.

  • The medicine is intended for adult patients with mild to moderately severe Alzheimer's-type dementia, which causes problems with memory, behavior, and intellectual abilities.

    Dosage form: plaster, transdermal system

    Active substance Dosage
    rivastigmine 6.9 mg

    ATC code: N06DA03

    Manufacturer: Luye Pharma AG

  • The medicine is used in adult patients with mild to moderately severe Alzheimer's-type dementia, which causes impairments in memory, intellectual abilities, and behavior.

    Dosage form: plaster, transdermal system

    Active substance Dosage
    rivastigmine 13.8 mg

    ATC code: N06DA03

    Manufacturer: Luye Pharma AG

  • The medicinal product is used in adult patients for the treatment of mild to moderately severe Alzheimer's type dementia and for the treatment of dementia associated with Parkinson's disease.

    Dosage form: capsules, hard

    Active substance Dosage
    rivastigmine hydrogen tartrate 2.4 mg

    ATC code: N06DA03

    Manufacturer: Genepharm S.A. neuraxpharm Arzneimittel GmbH

  • The medicinal product is used in adult patients to alleviate the symptoms of mild to moderately severe Alzheimer's-type dementia and dementia associated with Parkinson's disease.

    Dosage form: capsules, hard

    Active substance Dosage
    rivastigmine hydrogen tartrate 9.6 mg

    ATC code: N06DA03

    Manufacturer: Genepharm S.A. neuraxpharm Arzneimittel GmbH

  • The medicine is used in adult patients to relieve the symptoms of mild to moderately severe Alzheimer's-type dementia and dementia associated with Parkinson's disease.

    Dosage form: capsules, hard

    Active substance Dosage
    rivastigmine hydrogen tartrate 7.2 mg

    ATC code: N06DA03

    Manufacturer: Genepharm S.A. neuraxpharm Arzneimittel GmbH

  • The medicine is used in adult patients to alleviate the symptoms of mild to moderately severe Alzheimer's-type dementia and dementia associated with Parkinson's disease.

    Dosage form: capsules, hard

    Active substance Dosage
    rivastigmine hydrogen tartrate 4.8 mg

    ATC code: N06DA03

    Manufacturer: Genepharm S.A. neuraxpharm Arzneimittel GmbH

  • The medicine is used in adult patients to alleviate the symptoms of mild to moderately severe Alzheimer's-type dementia and dementia associated with Parkinson's disease.

    Dosage form: capsules, hard

    Active substance Dosage
    rivastigmine hydrogen tartrate 2.4 mg

    ATC code: N06DA03

    Manufacturer: Orion Corporation Orion Pharma

  • The medicinal product is used in adult patients for the treatment of mild to moderately severe Alzheimer's type dementia and for the treatment of dementia in people with Parkinson's disease.

    Dosage form: capsules, hard

    Active substance Dosage
    rivastigmine hydrogen tartrate 4.8 mg

    ATC code: N06DA03

    Manufacturer: Orion Corporation Orion Pharma

  • The medicine is used in adult patients to relieve the symptoms of mild to moderately severe Alzheimer's-type dementia and dementia associated with Parkinson's disease.

    Dosage form: capsules, hard

    Active substance Dosage
    rivastigmine hydrogen tartrate 7.2 mg

    ATC code: N06DA03

    Manufacturer: Orion Corporation Orion Pharma

  • The medicinal product is intended for adult patients with mild to moderately severe Alzheimer's-type dementia and for individuals with dementia caused by Parkinson's disease.

    Dosage form: capsules, hard

    Active substance Dosage
    rivastigmine hydrogen tartrate 9.6 mg

    ATC code: N06DA03

    Manufacturer: Orion Corporation Orion Pharma

  • Rivaxar is used in adults to reduce the risk of a subsequent heart attack or death from cardiovascular disease (in the case of acute coronary syndrome). It is also used to reduce the risk of blood clots in people with coronary artery disease or peripheral artery disease.

    Dosage form: tablets, film-coated

    Active substance Dosage
    rivaroxaban 2.5 mg

    ATC code: B01AF01

    Manufacturer: Adalvo Ltd. S.C. Labormed-Pharma S.A.

  • The medicine is used in adults to prevent the formation of blood clots in the veins following hip or knee replacement surgery, and to treat deep vein thrombosis and pulmonary embolism, as well as to prevent their recurrence.

    Dosage form: tablets, film-coated

    Active substance Dosage
    rivaroxaban 10 mg

    ATC code: B01AF01

    Manufacturer: Adalvo Ltd. S.C. Labormed-Pharma S.A.

  • The medicine is used in adults to prevent the formation of blood clots in the brain (stroke) and other blood vessels (in atrial fibrillation). It is also used to treat deep vein thrombosis in the legs and pulmonary embolism, as well as to prevent the recurrence of these clots.

    Dosage form: tablets, film-coated

    Active substance Dosage
    rivaroxaban 15 mg

    ATC code: B01AF01

    Manufacturer: Adalvo Ltd. S.C. Labormed-Pharma S.A.

  • The medicine is used in adults to prevent the formation of blood clots in the brain (stroke) and other blood vessels (e.g., in atrial fibrillation) and to treat and prevent the recurrence of thrombosis in the veins of the legs and in the blood vessels of the lungs.

    Dosage form: tablets, film-coated

    Active substance Dosage
    rivaroxaban 20 mg

    ATC code: B01AF01

    Manufacturer: Adalvo Ltd. S.C. Labormed-Pharma S.A.

  • The medicinal product is used topically to disinfect the skin and mucous membranes. It also helps in the supportive treatment of skin infections caused by bacteria (e.g., boils, abscesses) and in cases of mixed skin inflammation (bacterial and fungal), as well as after insect bites.

    Dosage form: gel

    Active substance Dosage
    etacridine lactate 5 mg

    ATC code: D08AA01

    Manufacturer: EMO-FARM Sp. z o.o.

  • It is used in adults to prevent the formation of blood clots in the veins following hip or knee replacement surgery, and for the treatment of deep vein thrombosis and pulmonary embolism, as well as to prevent their recurrence.

    Dosage form: tablets, film-coated

    Active substance Dosage
    rivaroxaban 10 mg

    ATC code: B01AF01

    Manufacturer: Genepharm S.A.

  • In adults, it is used to prevent strokes and blood clots (e.g., in atrial fibrillation) and for the treatment and prevention of deep vein thrombosis and pulmonary embolism. In children and adolescents (weighing more than 30 kg), it is used for the treatment and prevention of blood clots in the veins or lungs.

    Dosage form: tablets, film-coated

    Active substance Dosage
    rivaroxaban 20 mg

    ATC code: B01AF01

    Manufacturer: Genepharm S.A.

  • The medicine is used in adults to prevent strokes and other blood clots (e.g., in atrial fibrillation) and in the treatment and prevention of deep vein thrombosis and pulmonary embolism. In children and adolescents (over 30 kg), it is used for the treatment and prevention of clots following initial injectable treatment.

    Dosage form: tablets, film-coated

    Active substance Dosage
    rivaroxaban 15 mg

    ATC code: B01AF01

    Manufacturer: Genepharm S.A.

  • The medicine is used in adults to prevent strokes and other blood clots in the case of atrial fibrillation. In adults as well as children and adolescents (over 30 kg), it is used to treat deep vein thrombosis and pulmonary embolism and to prevent their recurrence.

    Dosage form: tablets, film-coated

    Active substance Dosage
    rivaroxaban 15 mg

    ATC code: B01AF01

    Manufacturer: Adamed Pharma S.A.

  • This medicine is used in adults to prevent strokes and other blood clots (e.g., in atrial fibrillation) and to treat and prevent blood clots in the veins of the legs and lungs. In children and adolescents (weighing more than 30 kg), it is used to treat blood clots after initial injectable treatment.

    Dosage form: tablets, film-coated

    Active substance Dosage
    rivaroxaban 20 mg

    ATC code: B01AF01

    Manufacturer: Adamed Pharma S.A.

  • The medicine is used in adults to prevent the formation of blood clots in the veins after hip or knee replacement surgery, and to treat deep vein thrombosis and pulmonary embolism, as well as to prevent their recurrence.

    Dosage form: tablets, film-coated

    Active substance Dosage
    rivaroxaban 10 mg

    ATC code: B01AF01

    Manufacturer: Adamed Pharma S.A.

  • This medicine is used in adults to reduce the risk of a subsequent heart attack or death from cardiovascular disease (following acute coronary syndrome). It is also used to reduce the risk of blood clots in people with coronary artery disease or peripheral artery disease.

    Dosage form: tablets, film-coated

    Active substance Dosage
    rivaroxaban 2.5 mg

    ATC code: B01AF01

    Manufacturer: Adamed Pharma S.A.

  • The medicine is used in adults to prevent the formation of blood clots in the veins after hip or knee replacement surgery, and to treat deep vein thrombosis and pulmonary embolism, as well as to prevent their recurrence.

    Dosage form: capsules, hard

    Active substance Dosage
    rivaroxaban 10 mg

    ATC code: B01AF01

    Manufacturer: Adamed Pharma S.A. Pharmadox Healthcare Limited Zentiva S.A.

  • In adults, it is used to prevent strokes and other blood clots (e.g., in atrial fibrillation) and to treat and prevent blood clots in the leg veins and pulmonary vessels. In children and adolescents (weighing more than 30 kg), it is used to treat blood clots after initial treatment with injections.

    Dosage form: capsules, hard

    Active substance Dosage
    rivaroxaban 15 mg

    ATC code: B01AF01

    Manufacturer: Adamed Pharma S.A. Pharmadox Healthcare Limited Zentiva S.A.

  • The medicine is used in adults to prevent strokes and other blood clots (e.g., in atrial fibrillation) and to treat and prevent clots in the leg veins and pulmonary vessels. In children and adolescents weighing more than 50 kg, it is used to treat clots after initial treatment with injections.

    Dosage form: capsules, hard

    Active substance Dosage
    rivaroxaban 20 mg

    ATC code: B01AF01

    Manufacturer: Adamed Pharma S.A. Pharmadox Healthcare Limited Zentiva S.A.

  • The medicine helps with a cough characterized by an excessive amount of difficult-to-expectorate secretion accumulating in the bronchi. It works by increasing mucus secretion and thinning the secretion, which facilitates its expectoration.

    Dosage form: syrup

    Active substance Dosage
    guaifenesin 100 mg/5 ml

    ATC code: R05CA03

    Manufacturer: Doppel Farmaceutici S.r.l.

  • This medicine is used in adults and children (from 2 years of age) during surgical procedures. It acts as a muscle relaxant, which facilitates the surgeon performing the operation under general anesthesia.

    Dosage form: solution for injection in ampoule-syringe

    Active substance Dosage
    rocuronium bromide 10 mg/ml

    ATC code: M03AC09

    Manufacturer: Laboratoire Aguettant

  • This is a medication from the group of muscle relaxants. It is used during surgery to completely relax the patient's muscles, which facilitates the surgical procedure. It may also be used to facilitate endotracheal intubation during general anesthesia.

    Dosage form: solution for injection for infusion

    Active substance Dosage
    rocuronium bromide 10 mg/ml

    ATC code: M03AC09

    Manufacturer: B. Braun Melsungen AG

  • This medicine belongs to a group of medicines that relax muscles. It is used during general anesthesia to facilitate the insertion of a breathing tube (to assist breathing) and to ensure complete muscle relaxation during surgery. It may also be used for short periods in intensive care units.

    Dosage form: solution for injection for infusion

    Active substance Dosage
    rocuronium bromide 10 mg/ml

    ATC code: M03AC09

    Manufacturer: hameln rds s.r.o.

  • The medicinal product is used as an aid in general anesthesia during surgery. Its purpose is to relax the patient's muscles, which facilitates the surgical procedure. Due to the relaxation of the respiratory muscles, the patient must be connected to a breathing support device while the drug is active.

    Dosage form: solution for injection for infusion

    Active substance Dosage
    rocuronium bromide 10 mg/ml

    ATC code: M03AC09

    Manufacturer: Demo S.A.

  • The medicine is used to relax muscles during surgical procedures, which facilitates the surgeon's work. It may also be used during general anesthesia to facilitate the insertion of an endotracheal tube into the trachea.

    Dosage form: solution for injection or infusion

    Active substance Dosage
    rocuronium bromide 10 mg/ml

    ATC code: M03AC09

    Manufacturer: Fresenius Kabi Austria GmbH

  • It is a muscle relaxant used during surgery as part of general anesthesia. It helps to relax the patient's muscles, which facilitates the surgical procedure. It may also be used in intensive care units for short-term muscle relaxation.

    Dosage form: solution for injection for infusion

    Active substance Dosage
    rocuronium bromide 10 mg/ml

    ATC code: M03AC09

    Manufacturer: AS Kalceks

  • The medicinal product is used to treat infections caused by bacteria sensitive to roxithromycin. This includes, among others, upper and lower respiratory tract infections (e.g., pharyngitis, sinusitis, pneumonia, bronchitis), otitis media, skin and soft tissue infections, and non-gonococcal genital tract infections.

    Dosage form: tablets, film-coated

    Active substance Dosage
    roxithromycin 50 mg

    ATC code: J01FA06

    Manufacturer: Tarchomin Pharmaceutical Works 'Polfa' S.A.

  • The medicine is used to treat infections caused by bacteria sensitive to roxithromycin. This includes, among others, inflammation of the tonsils, throat, sinuses, middle ear, lungs, and bronchi, as well as skin and soft tissue infections and non-gonococcal genital tract infections.

    Dosage form: tablets, film-coated

    Active substance Dosage
    roxithromycin 100 mg

    ATC code: J01FA06

    Manufacturer: Tarchomin Pharmaceutical Works 'Polfa' S.A.

  • The medicine is used to treat infections caused by bacteria sensitive to roxithromycin. This includes, among others, inflammation of the tonsils, throat, sinuses, middle ear, lungs, and bronchi, as well as skin and soft tissue infections and non-gonococcal genital tract infections.

    Dosage form: tablets, film-coated

    Active substance Dosage
    roxithromycin 150 mg

    ATC code: J01FA06

    Manufacturer: Tarchomin Pharmaceutical Works 'Polfa' S.A.

  • It is used in the treatment of Parkinson's disease to relieve its symptoms.

    Dosage form: tablets, prolonged release

    Active substance Dosage
    ropinirole 4 mg

    ATC code: N04BC04

    Manufacturer: Krka, d.d., Novo mesto

  • The medicine is used in the treatment of Parkinson's disease. It helps to relieve its symptoms by acting in the brain in a manner similar to naturally occurring dopamine.

    Dosage form: tablets, prolonged release

    Active substance Dosage
    ropinirole 8 mg

    ATC code: N04BC04

    Manufacturer: Krka, d.d., Novo mesto

  • The medicine is used to treat Parkinson's disease. It helps relieve its symptoms by acting in a manner similar to the dopamine naturally occurring in the brain.

    Dosage form: tablets, prolonged release

    Active substance Dosage
    ropinirole 8 mg

    ATC code: N04BC04

    Manufacturer: Krka d.d., Novo mesto

  • The medicine is used in the treatment of Parkinson's disease. It helps to relieve its symptoms by acting similarly to the dopamine naturally occurring in the brain.

    Dosage form: tablets, prolonged release

    Active substance Dosage
    ropinirole 4 mg

    ATC code: N04BC04

    Manufacturer: KRKA, d.d., Novo mesto

  • The medicine is used to treat high cholesterol levels in adults, adolescents, and children over 6 years of age. It helps to lower 'bad' cholesterol (LDL) levels and increase 'good' cholesterol (HDL) levels, which reduces the risk of heart attack or stroke.

    Dosage form: tablets, film-coated

    Active substance Dosage
    rosuvastatin calcium 20 mg

    ATC code: C10AA07

    Manufacturer: Polpharma Pharmaceutical Works S.A.

  • The medicine is used to treat high cholesterol levels in adults, adolescents, and children over 6 years of age. It helps to lower 'bad' cholesterol (LDL-C) levels and increase 'good' cholesterol (HDL-C) levels, which reduces the risk of heart attack or stroke.

    Dosage form: tablets, film-coated

    Active substance Dosage
    rosuvastatin calcium 40 mg

    ATC code: C10AA07

    Manufacturer: Polpharma Pharmaceutical Works S.A.

  • The medicine is used to treat high cholesterol in adults, adolescents, and children over 6 years of age. It helps to lower the level of 'bad' cholesterol (LDL-C) and increase the level of 'good' cholesterol (HDL-C), which reduces the risk of heart attack or stroke.

    Dosage form: tablets, film-coated

    Active substance Dosage
    rosuvastatin 15.6 mg

    ATC code: C10AA07

    Manufacturer: Polpharma Pharmaceutical Works S.A.